A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

NCT00720408 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation
Transplantation Immunology
Host vs Graft Reaction

Interventions

DRUG: Prograf-XL
DRUG: Prograf
DRUG: MMF

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]